|Other Accession||NP_085079.2, NP_000755.2|
|Other Names||Cytochrome P450 2A7, CYPIIA7, Cytochrome P450 IIA4, CYP2A7|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.|
|Cellular Location||Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CYP2A7 is a member of the cytochrome P450superfamily of enzymes. The cytochrome P450 proteins aremonooxygenases which catalyze many reactions involved in drugmetabolism and synthesis of cholesterol, steroids and other lipids.This protein localizes to the endoplasmic reticulum; its substratehas not yet been determined. CYP2A7, which produces twotranscript variants, is part of a large cluster of cytochrome P450genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome19q.
Fukami, T., et al. Pharmacogenomics J. 6(6):401-412(2006)Nelson, D.R., et al. Pharmacogenetics 14(1):1-18(2004)Oscarson, M., et al. Hum. Mutat. 20(4):275-283(2002)Godoy, W., et al. Carcinogenesis 23(4):611-616(2002)Koskela, S., et al. Biochem. Pharmacol. 57(12):1407-1413(1999)
If you have any additional inquiries please email technical services at email@example.com.